Todos Medical to Appoint Dr. Paula Trzepacz As Chief Medical Officer And Files New Patent Application
July 12, 2019 11:05 ET
|
Todos Medical Ltd.
Joint venture Breakthrough Diagnostics files new patent application covering Alzheimer’s blood diagnostic LymPro Test clinical correlation with amyloid PET imagingPreliminary Data on LymPro vs....
Todos Medical Announces Launch of Public Offering
July 11, 2019 09:15 ET
|
Todos Medical Ltd.
REHOVOT, Israel, July 11, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early...
Todos Medical to Sponsor the Investacure ‘Cure Coin Awards Reception’ for Alzheimer’s and CTE Research at AAIC 2019 in Los Angeles
June 27, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, June 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical CEO Presented Corporate Update And Roadmap at The LD Micro Conference
June 17, 2019 08:30 ET
|
Todos Medical Ltd.
REHOVOT, Israel, June 17, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Exercises Option to Acquire Remaining 80.01% of Breakthrough Diagnostics from Amarantus After Review of Alzheimer's Blood Test Data
May 28, 2019 08:57 ET
|
Todos Medical Ltd.
- Data demonstrated strong correlation between LymPro and amyloid PET- Todos to present at Alzheimer’s Solutions Conference on June 3, 2019 in Philadelphia- Todos to present at LD Micro on June 4th,...
Todos Medical Receives Approval from Israeli Ministry of Health (AMAR) to Market and Sell its Breast Cancer Screens in Israel
May 23, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, May 23, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro-diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Enters Exclusive Distribution Agreement with Care G.B. Plus, Ltd. for its Breast Cancer Screening Tests in Israel
May 21, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, May 21, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF) a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of...
Todos and Amarantus Announce Completion of LymPro PET 1 Study by Leipzig University for Alzheimer’s Blood Diagnostic LymPro Test 2.0
April 08, 2019 07:30 ET
|
Todos Medical Ltd.; Amarantus Bioscience Holdings, Inc.
REHOVOT, Israel and NEW YORK, April 08, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the...
Todos Medical Appoints Dr. Colin Bier to Its Board of Directors
March 27, 2019 08:00 ET
|
Todos Medical Ltd.
REHOVOT, Israel, March 27, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection...
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
February 28, 2019 09:30 ET
|
Todos Medical Ltd.; Amarantus Bioscience Holdings, Inc.
JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage...